Latest Takeda Pharmaceutical Company Stories
OSAKA, Japan, May 15, 2015 /PRNewswire/ -- Operational guidance met - Underlying revenue +2.8% year-over-year, in line with guidance
Lawsuit Help Center website reports that Takeda Pharmaceutical Co.
Bernstein Liebhard LLP is representing Actos lawsuit plaintiffs in the federal multidistrict litigation who are eligible to participate in this settlement. New
Attorneys from the Houston personal injury law firm of Fibich, Leebron, Copeland, Briggs & Josephson have helped negotiate a $2.4 Billion settlement for individuals injured after taking the prescription
Bernstein Liebhard LLP is currently evaluating the settlement on behalf if its Actos lawsuit clients and has updated its website to include the most current information regarding the proposed
- New Chief Operating Officer position has full accountability for taking the lead in building out novel go-to-market model, commercial capabilities and operational plans for ITCA 650.
Lawsuit Cash Advance Firm reports today that Takeda Pharmaceutical Co.
Parker Waichman, which has been actively involved in the Actos Litigation and represents many clients, notes that the deadline to enter into an Actos claim with the firm is rapidly approaching.
Attorneys Richard J. Arsenault of Neblett, Beard & Arsenault and Paul J. Pennock of Weitz & Luxenberg were the court-appointed co-lead Plaintiffs' counsel in the Multi-District Litigation (No.
Attorney Neil Overholtz, of Aylstock, Witkin, Kreis & Overholtz, PLLC in Pensacola, Florida, a court-appointed member of the Plaintiffs’ Steering Committee in the Multi-District Litigation
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.